Copyright: ©Author(s) 2026.
World J Diabetes. Mar 15, 2026; 17(3): 114603
Published online Mar 15, 2026. doi: 10.4239/wjd.v17.i3.114603
Published online Mar 15, 2026. doi: 10.4239/wjd.v17.i3.114603
Figure 2 The figure illustrates how diabetes alters systemic and retinal lipid pathways, fatty acid remodeling, cholesterol turnover, and sphingolipid balance, driving oxidative stress, inflammation, and barrier breakdown.
LDL: Low-density lipoprotein; HDL: High-density lipoprotein; DHA: Docosahexaenoic acid; PUFA: Polyunsaturated fatty acids; sEH: Soluble epoxide hydrolase; BRB: Blood-retinal barrier; ABCA1/ABCG1: ATP-binding cassette transporter A1/G1; CYP27A1/46A1: Cytochrome P450 27A1/46A1; ASM: Acid sphingomyelinase; ELOVL4: Elongases-VL4; VLC: Very long chain.
- Citation: Zeppieri M, Drigo A, Capobianco M, Visalli F, Cappellani F, Musa M, Giglio R, Tognetto D, Khouyyi M, Gagliano C, D’Esposito F, Inferrera L. Beyond glycemia: The influence of systemic inflammation, lipids, and the gut-retina axis in diabetic retinopathy. World J Diabetes 2026; 17(3): 114603
- URL: https://www.wjgnet.com/1948-9358/full/v17/i3/114603.htm
- DOI: https://dx.doi.org/10.4239/wjd.v17.i3.114603